Your Cart

Call us: +1 (870) 533-5581

Free shipping on all orders over $100 (US) and $300 (International)

Share

NAD+ (Nicotinamide Adenine Dinucleotide) 100 mg

$47.95

726 in stock

This item is selling fast!

Free shipping on all orders over $100 (US) and $300 (International)

Guaranteed Safe Checkout:

“SwissChems Payment Methods

Properties

  • Chemical Formula: C21H27N7O14P2
  • Molecular Mass: 663.4 g/mol
  • Synonyms: nadide, coenzyme I, beta-NAD, beta-nicotinamide adenine dinucleotide 
  • CAS Number: 53-84-9
  • PubChem: 5892
  • Total Amount of the Active Ingredient: 100 mg (1 vial)
  • Shelf Life: 36 months

Description

  • NAD+ is a coenzyme found in all living cells with a critical role in various biological processes, including energy metabolism and DNA repair. It is a vital molecule with significant implications for cellular biology and potential applications in health and longevity research.

Research on Nicotinamide Adenine Dinucleotide has garnered significant attention in recent years due to its crucial role in various biological processes. Some key research focuses on NAD+ including aging and longevity, metabolic health, neurodegenerative diseases, cellular repair, exercise and performance, mitochondrial function, cancer therapy, and drug development.

Some studies have explored its supplementation as a means to improve cellular function and potentially slow down the aging process. Its precursors, such as nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN), have gained attention for their potential to increase NAD+ levels.

NAD+ 100 mg should be reconstituted with bacteriostatic water (BAC).

Product Quality

All of our products are lab tested and the results are occasionally published on the website.

You can have the product you bought from us tested at any HPLC-licensed testing facility and if the results are negative, we will refund the following:

  • Cost of HPLC test
  • Total amount of the order + shipping fee

All of our products are lab tested and the results are periodically published on the website.

Peer-Reviewed Studies

Reiten, O. K., Wilvang, M. A., Mitchell, S. J., Hu, Z., & Fang, E. F. (2021). Preclinical and clinical evidence of NAD+ precursors in health, disease, and ageing. Mechanisms of ageing and development199, 111567. https://doi.org/10.1016/j.mad.2021.11156

Zapata-Pérez, R., Wanders, R. J. A., van Karnebeek, C. D. M., & Houtkooper, R. H. (2021). NAD+ homeostasis in human health and disease. EMBO molecular medicine13(7), e13943. https://doi.org/10.15252/emmm.202113943